Topiramate-induced weight loss is possibly due to the blockade of conditioned and automatic processes.
Khazaal
Yasser
Y
Zullino
Daniele Fabio
DF
D000855:Anorexia / Q000139:chemically induced; D019440:Anti-Obesity Agents / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use; D001066:Appetite / Q000187:drug effects; D003213:Conditioning, Psychological / Q000187:drug effects*; D002149:Energy Intake / Q000187:drug effects; D004734:Energy Metabolism / Q000187:drug effects / Q000502:physiology; D005632:Fructose / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000494:pharmacology / Q000627:therapeutic use; D006801:Humans; D008297:Male; D000077236:Topiramate; D015431:Weight Loss / Q000187:drug effects*
D019440:Anti-Obesity Agents; D000077236:Topiramate; D005632:Fructose